semaglutide and autoimmune Ozempic disease: Safety questions answered semaglutide autoimmune may Improve Metabolic

62 As it was underlined, GI AEs, although often transient and mild to moderate in severity, may affect treatment persistence

In the first half of 2025, Mounjaro sales alone approached several billion dollars, putting it on track to challenge Novos Wegovy/Ozempic for the highest sales in the weight loss/diabetes class

After an initial consultation with Dr

Many other groups have provided evidence to support and therefore confirm this phenomenon (14)

Trends Pharmacopsychiatry 28, 9099

You may remember that Avandia was actually pulled from the market because of increased heart failure risk, and that this led to a revolution in diabetes care prioritizing cardiovascular safety before diabetes drugs could be FDA approved